Abstract
Acute lung injury is a life-threating condition characterized by surfactant dysfunction and raised secretory phospholipase A2 (sPLA2) activity. Varespladib is a sPLA2 inhibitor shown to be effective in animal models of acute lung injury. We aimed at investigating the effect of co-administration of surfactant and varespladib on sPLA2 activity. Alveolar macrophages were cultured and stimulated with lipopolysaccharide and then treated with either varespladib, surfactant, varespladib followed by surfactant or nothing. sPLA2 activity, free fatty acids, tumour necrosis factor-α (TNF-α) and protein concentrations were measured in culture supernatants. Treatment with varespladib (p=0.019) and varespladib + surfactant (p=0.013), reduced the enzyme activity by approximately 15% from the basal level measured in the untreated cultures. Surfactant, varespladib and varespladib + surfactant, respectively decreased free fatty acids by -45% (p=0.045), - 62% (p=0.009) and -48% (p=0.015), from the baseline concentration of the untreated cultures. Varespladib and poractant- α co-administration reduces sPLA2 activity and free fatty acids release in cultured rat alveolar macrophages, although a clear drug synergy was not evident. Since co-administration may be useful to reduce inflammation and surfactant inactivation in acute lung injury, further in vivo studies are warranted to verify its clinical usefulness.
Keywords: Acute lung injury, secretory phospholipase A2, varespladib, surfactant.
Current Pharmaceutical Biotechnology
Title:Surfactant and Varespladib Co-Administration in Stimulated Rat Alveolar Macrophages Culture
Volume: 14 Issue: 4
Author(s): Daniele De Luca, Francesca Vendittelli, Joaquim Trias, Heather Fraser, Angelo Minucci, Leonarda Gentile, Jesus Perez-Gil, Giorgio Conti, Massimo Antonelli and Ettore D. Capoluongo
Affiliation:
Keywords: Acute lung injury, secretory phospholipase A2, varespladib, surfactant.
Abstract: Acute lung injury is a life-threating condition characterized by surfactant dysfunction and raised secretory phospholipase A2 (sPLA2) activity. Varespladib is a sPLA2 inhibitor shown to be effective in animal models of acute lung injury. We aimed at investigating the effect of co-administration of surfactant and varespladib on sPLA2 activity. Alveolar macrophages were cultured and stimulated with lipopolysaccharide and then treated with either varespladib, surfactant, varespladib followed by surfactant or nothing. sPLA2 activity, free fatty acids, tumour necrosis factor-α (TNF-α) and protein concentrations were measured in culture supernatants. Treatment with varespladib (p=0.019) and varespladib + surfactant (p=0.013), reduced the enzyme activity by approximately 15% from the basal level measured in the untreated cultures. Surfactant, varespladib and varespladib + surfactant, respectively decreased free fatty acids by -45% (p=0.045), - 62% (p=0.009) and -48% (p=0.015), from the baseline concentration of the untreated cultures. Varespladib and poractant- α co-administration reduces sPLA2 activity and free fatty acids release in cultured rat alveolar macrophages, although a clear drug synergy was not evident. Since co-administration may be useful to reduce inflammation and surfactant inactivation in acute lung injury, further in vivo studies are warranted to verify its clinical usefulness.
Export Options
About this article
Cite this article as:
Luca Daniele De, Vendittelli Francesca, Trias Joaquim, Fraser Heather, Minucci Angelo, Gentile Leonarda, Perez-Gil Jesus, Conti Giorgio, Antonelli Massimo and Capoluongo Ettore D., Surfactant and Varespladib Co-Administration in Stimulated Rat Alveolar Macrophages Culture, Current Pharmaceutical Biotechnology 2013; 14 (4) . https://dx.doi.org/10.2174/1389201011314040010
DOI https://dx.doi.org/10.2174/1389201011314040010 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Fullerenes in Medicinal Chemistry and their Biological Applications
Mini-Reviews in Medicinal Chemistry Thematic Analysis™ : A Chemogenomic Approach to GPCR Drug Discovery
Current Topics in Medicinal Chemistry The Chemistry of Galanthamine. Classical Synthetic Methods and Comprehensive Study on its Analogues
Mini-Reviews in Medicinal Chemistry Schiff Bases of Istain: Potential Anti-Leishmanial Agents
Letters in Drug Design & Discovery The Molecular Basis for the Mode of Action of Bicyclomycin
Current Drug Targets - Infectious Disorders Detection of COVID-19 Incidentally in <sup>68</sup>Ga-PSMA PET/CT for Restaging of Prostate Cancer
Current Medical Imaging Structure-Activity Relationship Studies: M2 and CCR5 Receptor Antagonists
Current Topics in Medicinal Chemistry Radiotherapy for Non-Melanoma Skin Cancer
Current Cancer Therapy Reviews Coronavirus Pandemic: Role of Bats And Zoonotic Transmission in Humans
Coronaviruses Rational Design, Synthesis and In Vitro Evaluation of Three New Alkylating Steroidal Esters
Medicinal Chemistry Current Scenario and Future Prospect in the Management of COVID-19
Current Medicinal Chemistry <i>Opuntia ficus indica</i> (L.) Mill. An Ancient Plant Source of Nutraceuticals
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Drug Metabolism New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase
Current Protein & Peptide Science Ivermectin in COVID-19 Management: What is the Current Evidence?
Infectious Disorders - Drug Targets Discovery and Development of Antifungal Compounds
Current Medicinal Chemistry - Anti-Infective Agents Induction of a Robust Humoral Response using HIV-1 VLP<sup>MPER-V3</sup> as a Novel Candidate Vaccine in BALB/c Mice
Current HIV Research Coronavirus Disease 2019: Hysteresis Effect of Chest CT and the Correlation with its Severity
Current Medical Imaging Isolation, Structural Determination, and Evaluation of the Biological Activity of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol [20(S)-25-OCH3-PPD], a Novel Natural Product from Panax notoginseng
Medicinal Chemistry